WallStreetZenWallStreetZen

NASDAQ: EVGN
Evogene Ltd Stock Ownership - Who owns Evogene?

Insider buying vs selling

Have Evogene Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when EVGN insiders and whales buy or sell their stock.

EVGN Shareholders

What type of owners hold Evogene Ltd stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Silverarc Capital Management LLC6.13%3,100,000$2.04MInstitution
Walleye Capital LLC0.69%349,477$230.31kInstitution
Morgan Stanley0.37%188,446$124.19kInstitution
Bnp Paribas Financial Markets0.14%69,900$46.06kInstitution
Lpl Financial LLC0.13%66,835$44.04kInstitution
Jpmorgan Chase Co0.13%64,594$42.57kInstitution
Geode Capital Management LLC0.12%59,007$38.89kInstitution
Citadel Advisors LLC0.11%56,720$37.38kInstitution
Ubs Group Ag0.11%56,005$36.91kInstitution
Renaissance Technologies LLC0.09%44,800$29.52kInstitution

1 of 3

EVGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EVGN8.48%0.00%
ACHL53.02%0.00%
INKT2.85%72.02%Net BuyingNet Buying
CASI0.35%99.65%
DARE6.57%25.43%

Evogene Stock Ownership FAQ

Who owns Evogene?

Evogene (NASDAQ: EVGN) is owned by 8.48% institutional shareholders, 0.00% Evogene insiders, and 91.52% retail investors. Silverarc Capital Management LLC is the largest individual Evogene shareholder, owning 3.10M shares representing 6.13% of the company. Silverarc Capital Management LLC's Evogene shares are currently valued at $1.94M.

If you're new to stock investing, here's how to buy Evogene stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.